Lohocla 201

Drug Profile

Lohocla 201

Alternative Names: Kindolor®; Lohocla-201

Latest Information Update: 27 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lohocla Research
  • Class Analgesics; Small molecules
  • Mechanism of Action Nav1.7-voltage-gated-sodium-channel-modulators; Nav1.8 voltage-gated sodium channel modulators; NMDA receptor modulators; Opioid delta receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Anxiety disorders; Pain

Most Recent Events

  • 27 Oct 2016 Lohocla Research has patent protection for Lohalca 201 in USA, France, Germany, Switzerland and United Kingsom (Lohocla Research website, October 2016)
  • 27 Oct 2016 Lohocla Research has patents pending for Lohocla 201 in USA and Europe (Lohocla Research website, October 2016)
  • 27 Oct 2016 Preclinical trials in Anxiety disorders in USA (PO) before October 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top